Search Results

There are 1906 results for: content related to: Systemic administration of β 2 -adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses

  1. Regular treatment with formoterol for chronic asthma: serious adverse events

    Intervention Review

    The Cochrane Library

    Christopher J Cates and Matthew J Cates

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD006923.pub3

  2. You have free access to this content
    Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events

    Intervention Review

    The Cochrane Library

    Christopher J Cates, Roman Jaeschke, Stefanie Schmidt and Montse Ferrer

    Published Online : 7 JUN 2013, DOI: 10.1002/14651858.CD006924.pub3

  3. You have free access to this content
    Long-acting beta2-agonists for chronic obstructive pulmonary disease

    Intervention Review

    The Cochrane Library

    Kayleigh M Kew, Chris Mavergames and Julia AE Walters

    Published Online : 15 OCT 2013, DOI: 10.1002/14651858.CD010177.pub2

  4. You have free access to this content
    Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Christopher J Cates, L. Susan Wieland, Marta Oleszczuk and Kayleigh M Kew

    Published Online : 6 FEB 2014, DOI: 10.1002/14651858.CD010314.pub2

  5. You have free access to this content
    Cochrane review: Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 5, Issue 3, September 2010, Pages: 1456–1542, Christopher J Cates, Toby J Lasserson and Roman Jaeschke

    Version of Record online : 7 OCT 2010, DOI: 10.1002/ebch.583

  6. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma

    Intervention Review

    The Cochrane Library

    Emma J Welsh and Christopher J Cates

    Published Online : 8 SEP 2010, DOI: 10.1002/14651858.CD008418.pub2

  7. You have free access to this content
    Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Kayleigh M Kew, Sofia Dias and Christopher J Cates

    Published Online : 26 MAR 2014, DOI: 10.1002/14651858.CD010844.pub2

  8. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children

    Intervention Review

    The Cochrane Library

    Christopher J Cates and Toby J Lasserson

    Published Online : 21 JAN 2009, DOI: 10.1002/14651858.CD007085.pub2

  9. You have free access to this content
    Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Christopher J Cates, Marta Oleszczuk, Elizabeth Stovold and L. Susan Wieland

    Published Online : 17 OCT 2012, DOI: 10.1002/14651858.CD010005.pub2

  10. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

    Intervention Review

    The Cochrane Library

    Christopher J Cates and Toby J Lasserson

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD007694.pub2

  11. Efficacy and safety of high-dose budesonide/formoterol (Symbicort®) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma

    Respirology

    Volume 11, Issue 3, May 2006, Pages: 276–286, Christine JENKINS, Renata KOLARIKOVA, Piotr KUNA, Denis CAILLAUD, Joaquin SANCHIS, Wolfgang POPP and Eva PETTERSSON

    Version of Record online : 19 APR 2006, DOI: 10.1111/j.1440-1843.2006.00856.x

  12. You have free access to this content
    Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma

    Allergy

    Volume 63, Issue 12, December 2008, Pages: 1567–1580, M. Humbert, T. L. G. Andersson and R. Buhl

    Version of Record online : 12 NOV 2008, DOI: 10.1111/j.1398-9995.2008.01863.x

  13. Dose-related efficacy and safety of formoterol (Oxis®) Turbuhaler® compared with salmeterol Diskhaler® in children with asthma

    Pediatric Allergy and Immunology

    Volume 15, Issue 1, February 2004, Pages: 32–39, Petr Pohunek, Milan Matulka, Ondřej Rybníček, František Kopřiva, Helena Honomichlová and Tamara Svobodová

    Version of Record online : 1 MAR 2004, DOI: 10.1046/j.0905-6157.2003.00096.x

  14. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events

    Intervention Review

    The Cochrane Library

    Christopher J Cates and Toby J Lasserson

    Published Online : 14 MAR 2012, DOI: 10.1002/14651858.CD007695.pub3

  15. You have free access to this content
    Stereoselective urinary excretion of formoterol and its glucuronide conjugate in human

    British Journal of Clinical Pharmacology

    Volume 54, Issue 3, September 2002, Pages: 246–250, Mei Zhang, J. Paul Fawcett and John P. Shaw

    Version of Record online : 18 SEP 2002, DOI: 10.1046/j.1365-2125.2002.01641.x

  16. You have free access to this content
    Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

    Intervention Review

    The Cochrane Library

    Luis Javier Nannini, Phillippa Poole, Stephen J Milan, Rebecca Holmes and Rebecca Normansell

    Published Online : 10 NOV 2013, DOI: 10.1002/14651858.CD003794.pub4

  17. You have free access to this content
    Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms

    British Journal of Pharmacology

    Volume 163, Issue 3, June 2011, Pages: 521–532, PR Cooper, RC Kurten, J Zhang, DJ Nicholls, IA Dainty and RA Panettieri

    Version of Record online : 11 MAY 2011, DOI: 10.1111/j.1476-5381.2011.01257.x

  18. Pharmacokinetics of Budesonide and Formoterol Administered Via 1 Pressurized Metered-Dose Inhaler in Patients With Asthma and COPD

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1300–1308, Dr Ann Tronde, Mr Michael Gillen, Dr Lars Borgström, Dr Jan Lötvall and Dr Jaro Ankerst

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008322122

  19. You have free access to this content
    Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition

    British Journal of Pharmacology

    Volume 167, Issue 4, October 2012, Pages: 775–786, C Rossios, Y To, G Osoata, M Ito, PJ Barnes and K Ito

    Version of Record online : 25 SEP 2012, DOI: 10.1111/j.1476-5381.2012.01864.x

  20. Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: Phase III multinational study results

    Respirology

    Volume 18, Issue 5, July 2013, Pages: 866–873, Yoshinosuke Fukuchi, Ronnie Samoro, Rustem Fassakhov, Hiroyuki Taniguchi, Jan Ekelund, Lars-Goran Carlsson and Masakazu Ichinose

    Version of Record online : 21 JUN 2013, DOI: 10.1111/resp.12090